_1777294237270_124456903.png&w=64&q=75){kind=small}
Arabian Pharmaceuticals plans sale of 10.49% Al-Dawaa stake
GIB Capital has announced the launch of the order book-building process to sell its 10.49% stake in Al-Dawaa Medical Services Company, a Saudi pharmaceutical and medical supplies firm. The sale process includes the sale of up to 12.588 million shares of the company's capital to institutional investors. The aim of this process is to increase liquidity and strengthen the company's capital by offering its stake to the market. The company has not disclosed a specific timeline for the implementation.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)